Sudden cardiac death echocardiography and ultrasound: Difference between revisions
Jump to navigation
Jump to search
/* 2022 ESC Guidelines for the management of patients with ventricular arrythymias and the prevention of sudden cardiac death {{cite journal| author=Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA | display-authors=etal| title=2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. | journal=Eur Heart J | year= 2022 | volume= 43 | issue= 40 | pages= 3997-4126 | pmid=36017572 | doi=10.1093/eurheartj/ehac26... |
|||
| Line 24: | Line 24: | ||
{|class="wikitable" | {|class="wikitable" | ||
|- | |- | ||
| colspan="1" style="text-align:center; background: Silver"|Recommendations for evaluation of sudden cardiac arrest survivors'' | | colspan="1" style="text-align:center; background: Silver"|'''Recommendations for evaluation of sudden cardiac arrest survivors''''' | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LemonChiffon"|[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class IIa]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])'' | | colspan="1" style="text-align:center; background:LemonChiffon"|'''[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class IIa]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])''''' | ||
|- | |- | ||
| bgcolor="LemonChiffon"| | | bgcolor="LemonChiffon"| | ||
* In [[SCA]] survivors, [[brain]]/ [[chest]] [[CT scan]] should be considered when [[patient]] characteristics, [[ECG]], and [[echocardiography]] are not consistent with a [[cardiac]] cause. | * In [[SCA]] survivors, [[brain]]/ [[chest]] [[CT scan]] should be considered when [[patient]] characteristics, [[ECG]], and [[echocardiography]] are not consistent with a [[cardiac]] cause. | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])'' | | colspan="1" style="text-align:center; background:LightGreen"|'''[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])''''' | ||
|- | |- | ||
| bgcolor="LightGreen"| | | bgcolor="LightGreen"| | ||
| Line 39: | Line 39: | ||
{|class="wikitable" | {|class="wikitable" | ||
|- | |- | ||
| colspan="1" style="text-align:center; background: Silver"|Recommendation for management of relatives of a patient with aarhythmogenic right ventricular cardiomyopathy'' | | colspan="1" style="text-align:center; background: Silver"|'''Recommendation for management of relatives of a patient with aarhythmogenic right ventricular cardiomyopathy''''' | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])'' | | colspan="1" style="text-align:center; background:LightGreen"|'''[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])''''' | ||
|- | |- | ||
| bgcolor="LightGreen"| | | bgcolor="LightGreen"| | ||
| Line 59: | Line 59: | ||
{|class="wikitable" | {|class="wikitable" | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B]])'' | | colspan="1" style="text-align:center; background:LightGreen"|'''[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B]])''''' | ||
|- | |- | ||
| Line 68: | Line 68: | ||
{|class="wikitable" | {|class="wikitable" | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])'' | | colspan="1" style="text-align:center; background:LightGreen"|'''[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])''''' | ||
|- | |- | ||
Latest revision as of 18:38, 22 July 2023
|
Sudden cardiac death Microchapters |
|
Diagnosis |
|---|
|
Sudden cardiac death echocardiography and ultrasound On the Web |
|
American Roentgen Ray Society Images of Sudden cardiac death echocardiography and ultrasound |
|
Sudden cardiac death echocardiography and ultrasound in the news |
|
Blogs on Sudden cardiac death echocardiography and ultrasound |
|
Risk calculators and risk factors for Sudden cardiac death echocardiography and ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Edzel Lorraine Co, DMD, MD[3]
Overview
Echocardiography may be helpful in the diagnosis the cause of lethal arrhythmia and sudden cardiac arrest.
Echocardiography
Echocardiography may be helpful in the diagnosis the cause of lethal arrhythmia and sudden cardiac arrest by assessment of the following:
- Regional wall motion abnormality
- Systolic function of left ventricle
- Evidence of myocardial infarction
- Valvular heart disease such as aortic stenosis
- Right ventricular cardiomyopathy
- Pericardial effusion
- Tamponade
- Aorta dissection [1]
2022 ESC Guidelines for the management of patients with ventricular arrythymias and the prevention of sudden cardiac death [2]
| Recommendations for evaluation of sudden cardiac arrest survivors |
| Class IIa (Level of Evidence: C) |
| Class I (Level of Evidence: C) |
|
| Recommendation for management of relatives of a patient with aarhythmogenic right ventricular cardiomyopathy |
| Class I (Level of Evidence: C) |
|
| Recommendation for management of relatives of a patient with hypertrophic cardiomyopathy |
| Class I (Level of Evidence: C) |
|
| Class I (Level of Evidence: B) |
|
| Class I (Level of Evidence: C) |
|
2017AHA/ACC/HRS Guideline for management of sudden cardiac arrest and ventricular arrhythmia
| Class I (Level of Evidence: B) |
|
References
- ↑ Parker, Brian K.; Salerno, Alexis; Euerle, Brian D. (2018). "The Use of Transesophageal Echocardiography During Cardiac Arrest Resuscitation: A Literature Review". Journal of Ultrasound in Medicine. 38 (5): 1141–1151. doi:10.1002/jum.14794. ISSN 0278-4297.
- ↑ Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA; et al. (2022). "2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death". Eur Heart J. 43 (40): 3997–4126. doi:10.1093/eurheartj/ehac262. PMID 36017572 Check
|pmid=value (help). - ↑ Al-Khatib, Sana M.; Stevenson, William G.; Ackerman, Michael J.; Bryant, William J.; Callans, David J.; Curtis, Anne B.; Deal, Barbara J.; Dickfeld, Timm; Field, Michael E.; Fonarow, Gregg C.; Gillis, Anne M.; Granger, Christopher B.; Hammill, Stephen C.; Hlatky, Mark A.; Joglar, José A.; Kay, G. Neal; Matlock, Daniel D.; Myerburg, Robert J.; Page, Richard L. (2018). "2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death". Circulation. 138 (13). doi:10.1161/CIR.0000000000000549. ISSN 0009-7322.